STAAR SURGICAL CO (STAA) research
STAAR SURGICAL CO- Sector
- Health Care
- Last price
- $22.47
- As of
STAAR SURGICAL CO (STAA): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-10.
As of . Source: SEC EDGAR filings for STAA. Method and limitations.
Share the STAA intelligence card
See the full STAA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for STAA on one page. Preview it with sample data, then open it live with a free account.
Preview the STAA dossierActive signals for STAA
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +196% to STAA (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +152% to STAA (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 63% of STAA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +64% to STAA (2026Q2)
- highINSTITUTIONAL_EXIT
TWO SIGMA INVESTMENTS, LP cut 80% of STAA (2026Q2)
FREE, NO ACCOUNT
Every signal on STAA, as it fires
You are seeing 5 of 17 signals recorded on STAA since 2026-05-26.
The five above all landed on 2026-08-16. The other 12 were recorded on 4 other days. 10 of the 17 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in STAA (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 852312305 · 2026Q2 | $69.9M | 0.08% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 852312305 · 2026Q2 | $9.8M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 852312305 · 2026Q2 | $6.7M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 852312305 · 2026Q2 | $3.2M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 852312305 · 2026Q2 | $631K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, STAA
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
STAA against its peers
STAA's operating margin of -38.3% ranks in the 2nd percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-01-02.
| Metric | STAA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 239M USD | 797M USD | 10 | 25 |
| Gross margin | 76.2% | 54.6% | 91 | 15 |
| Operating margin | -38.3% | 1.4% | 2 | 25 |
| Net margin | -33.6% | -0.4% | 2 | 25 |
| Return on equity | -23.4% | -0.4% | 21 | 25 |
| P / E | n/a | 43.3x | n/a | 10 |
Peers (25): GDRX, TNDM, IRMD, OMDA, CSTL, TDOC, PRCT, USPH, PNTG, AMN, CNMD, BVS, HSTM, CERT, TALK, OMCL, ATEC, VREX, ALHC, AHCO, EHAB, XRAY, NVCR, LMAT, PGNY. Fiscal periods ending between 2025-10-03 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (STAA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more STAA signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to STAAand get the insider, 13F, options, and confluence read in one view.